AFP on MSN10 小时
'I will fight': Khelif responds to boxing organisation lawsuit
Algerian gold winning boxer Imane Khelif has denounced "false and offensive" allegations after the International Boxing ...
Imane Khelif denounces IBA’s gender eligibility claims as ‘false and offensive’
Algerian gold winning boxer Imane Khelif has denounced “false and offensive” allegations after the International Boxing ...
eLife20 小时
Enalapril mitigates aging by targeting antioxidative genes via phosphorylated Smad1/5/9
In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...
Le Lézard3 小时
FDA Approves Genentech's Evrysdi Tablet as First and Only Tablet for Spinal Muscular ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® ...
Kauppalehti3 小时
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy ...
"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...
F. Hoffmann-La Roche Ltd: FDA approves Roche's Evrysdi tablet as first and only tablet for ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...